Barclays PLC Omeros Corp Call Options Transaction History

Barclays PLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2019 Feb 10, 2020	SELL	$13.01 - $17.15 $2,602 - $3,429	-200 Reduced 10.0%	1,800 $25,000
Q3 2019 Nov 14, 2019	SELL	$14.55 - $20.56 $2,910 - $4,112	-200 Reduced 9.09%	2,000 $33,000
Q2 2019 Aug 14, 2019	SELL	$15.0 - $19.62 $150,000 - $196,200	-10,000 Reduced 81.97%	2,200 $35,000
Q1 2019 May 15, 2019	BUY	$11.65 - $17.72 $45,435 - $69,108	3,900 Added 46.99%	12,200 $212,000
Q4 2018 Feb 14, 2019	BUY	$10.72 - $16.73 $82,544 - $128,821	7,700 Added 1283.33%	8,300 $92,000
Q2 2018 Aug 14, 2018	SELL	$10.79 - $24.44 $84,162 - $190,632	-7,800 Reduced 92.86%	600 $11,000
Q1 2018 May 15, 2018	BUY	$9.0 - $20.16 $64,800 - $145,152	7,200 Added 600.0%	8,400 $94,000
Q4 2017 Feb 14, 2018	BUY	$13.26 - $22.86 $13,260 - $22,860	1,000 Added 500.0%	1,200 $23,000
Q3 2017 Nov 14, 2017	BUY	$19.76 - $24.9 $3,952 - $4,980	200	200 $4,000

121

25.6M

228K

630K

Ticker OMER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,730,000
Market Cap $555M
Description
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.